128 related articles for article (PubMed ID: 20845807)
1. The effects of growth inhibitory peptide on follicular thyroid cancer cell growth, migration, and invasion.
Hua SC; Chen SY; Lu CH; Kao YT; Yu HI; Chen PT; Lee YR; Chang TC
Tumori; 2010; 96(3):448-51. PubMed ID: 20845807
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
McLaughlin PJ; Zagon IS; Park SS; Conway A; Donahue RN; Goldenberg D
BMC Cancer; 2009 Oct; 9():369. PubMed ID: 19835629
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
5. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
[TBL] [Abstract][Full Text] [Related]
7. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.
Zwanziger D; Badziong J; Ting S; Moeller LC; Schmid KW; Siebolts U; Wickenhauser C; Dralle H; Fuehrer D
Endocr Relat Cancer; 2015 Oct; 22(5):819-30. PubMed ID: 26219679
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
Hoelting T; Siperstein AE; Duh QY; Clark OH
J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
[TBL] [Abstract][Full Text] [Related]
10. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
11. FUT7 promotes the malignant transformation of follicular thyroid carcinoma through α1,3-fucosylation of EGF receptor.
Qin H; Liu J; Yu M; Wang H; Thomas AM; Li S; Yan Q; Wang L
Exp Cell Res; 2020 Aug; 393(2):112095. PubMed ID: 32442537
[TBL] [Abstract][Full Text] [Related]
12. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767
[TBL] [Abstract][Full Text] [Related]
13. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.
Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956
[TBL] [Abstract][Full Text] [Related]
14. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma.
Kim HJ; Sung JY; Oh YL; Kim JH; Son YI; Min YK; Kim SW; Chung JH
Head Neck; 2014 Dec; 36(12):1695-700. PubMed ID: 24115217
[TBL] [Abstract][Full Text] [Related]
15. The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
Lin J; Qiu Y; Zheng X; Dai Y; Xu T
BMC Cancer; 2022 Jul; 22(1):756. PubMed ID: 35818041
[TBL] [Abstract][Full Text] [Related]
16. Threshold primary tumour sizes for nodal and distant metastases in papillary and follicular thyroid cancers.
Zaman Mu; Fatima N; Sajjad Z; Akhtar J; Islam N; Masood Q; Ahmed A
Asian Pac J Cancer Prev; 2012; 13(6):2473-6. PubMed ID: 22938406
[TBL] [Abstract][Full Text] [Related]
17. Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors.
Cirello V; Vaira V; Grassi ES; Vezzoli V; Ricca D; Colombo C; Bosari S; Vicentini L; Persani L; Ferrero S; Fugazzola L
Oncotarget; 2017 Feb; 8(6):9752-9766. PubMed ID: 28039458
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
Hoelting T; Duh QY; Clark OH; Herfarth C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
[TBL] [Abstract][Full Text] [Related]
19. Autophagy induction of reversine on human follicular thyroid cancer cells.
Lu CH; Liu YW; Hua SC; Yu HI; Chang YP; Lee YR
Biomed Pharmacother; 2012 Dec; 66(8):642-7. PubMed ID: 23089471
[TBL] [Abstract][Full Text] [Related]
20. Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses.
Schmutzler C; Hoang-Vu C; Rüger B; Köhrle J
Eur J Endocrinol; 2004 Apr; 150(4):547-56. PubMed ID: 15080786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]